{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:59Z","timestamp":1791996779716,"version":"4.4.0"},"reference-count":285,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpc.2025.101073","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T06:58:53Z","timestamp":1754549933000},"page":"101073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["High-density lipoproteins. Part 2. Impact of disease states on functionality"],"prefix":"10.1016","volume":"23","author":[{"given":"Anna","family":"Gluba-Sagr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Franczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"M\u0142ynarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Rysz-G\u00f3rzy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-6664","authenticated-orcid":false,"given":"Stanislaw","family":"Surma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-6135","authenticated-orcid":false,"given":"Sheth","family":"Sohum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-5460","authenticated-orcid":false,"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.101073_bib0001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","article-title":"Molecular physiology of reverse cholesterol transport","volume":"36","author":"Fielding","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0002","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: a consensus statement from the National Lipid Association","volume":"7","author":"Toth","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.96.1.37","article-title":"LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994","volume":"96","author":"Ferrara","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117270","article-title":"Sex differences in lipids: A life course approach","volume":"384","author":"Holven","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0021-9150(84)90157-6","article-title":"Cigarette smoking, exercise and high density lipoprotein cholesterol","volume":"52","author":"Stamford","year":"1984","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0006","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0007","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0008","unstructured":"https:\/\/www.biopharmadive.com\/news\/newamsterdam-alzheimers-biomarkers-drug-cardiovascular-trial\/750216\/."},{"key":"10.1016\/j.ajpc.2025.101073_bib0009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MED.0000000000000230","article-title":"Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future","volume":"23","author":"Burgess","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ajpc.2025.101073_bib0011","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.athplu.2023.04.001","article-title":"HDL and chronic kidney disease","volume":"52","author":"Pavanello","year":"2023","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.ajpc.2025.101073_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194797","article-title":"Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry","volume":"13","author":"Kuklenyik","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2025.101073_bib0014","volume":"9","author":"Bonizzi","year":"2021","journal-title":"Clinical Relevance of Quality Rather Than Quantity. Biomedicines"},{"key":"10.1016\/j.ajpc.2025.101073_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2021.159072","article-title":"The HDL proteome Watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","author":"Kontush","year":"2015","journal-title":"High Density Lipoproteins: From Biological Understanding to Clinical Exploitation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0017","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-153-12-201012210-00006","article-title":"Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk","volume":"153","author":"Jafri","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0018","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212525","article-title":"High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease","volume":"7","author":"Kosmas","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.ajpc.2025.101073_bib0019","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome1","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0020","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14797\/mdcj-15-1-55","article-title":"High-density lipoprotein subspecies in health and human disease: focus on type 2 diabetes","volume":"15","author":"Davidson","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0022","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond1","volume":"54","author":"Shah","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e328338472d","article-title":"High-density lipoprotein heterogeneity and function in reverse cholesterol transport","volume":"21","author":"Rothblat","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0024","first-page":"112","article-title":"HDL functionality in type 1 and type 2 diabetes: new insights. Current Opinion in Endocrinology","volume":"29","author":"Chapman","year":"2022","journal-title":"Diabetes and Obesity"},{"key":"10.1016\/j.ajpc.2025.101073_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1194\/jlr.M200414-JLR200","article-title":"Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations","volume":"44","author":"Basso","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","article-title":"HDL and atherosclerosis: insights from inherited HDL disorders","volume":"1851","author":"Calabresi","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-017-3165-z","article-title":"Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease","volume":"440","author":"Srivastava","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0028","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9150(99)00150-1","article-title":"Remodelling of high density lipoproteins by plasma factors","volume":"145","author":"Rye","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0029","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbrc.2010.10.053","article-title":"PPAR\u03b3 activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells","volume":"402","author":"Mogilenko","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpc.2025.101073_bib0030","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1074\/jbc.M010265200","article-title":"Specific docking of apolipoprotein AI at the cell surface requires a functional ABCA1 transporter","volume":"276","author":"Chambenoit","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0031","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/296417","article-title":"Dysfunctional high-density lipoprotein: an innovative target for proteomics and lipidomics","author":"Salazar","year":"2015","journal-title":"Cholesterol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0033","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOL.0000000000000642","article-title":"Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL","volume":"30","author":"Bonacina","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2012.08.020","article-title":"HDL and adaptive immunity: a tale of lipid rafts","volume":"225","author":"Norata","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbalip.2017.05.005","article-title":"Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F(1)-ATPase-mediated HDL endocytosis pathway on hepatocytes","volume":"1862","author":"Cardouat","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/abbs\/gms100","article-title":"Antioxidant effect of apolipoprotein AI on high-fat diet-induced non-alcoholic fatty liver disease in rabbits","volume":"45","author":"Wang","year":"2013","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.ajpc.2025.101073_bib0037","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fphar.2015.00222","article-title":"Antioxidant properties of HDL","volume":"6","author":"Soran","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0038","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","article-title":"Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells","volume":"318","author":"Mackness","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpc.2025.101073_bib0039","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0040","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1194\/jlr.R037762","article-title":"High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1","volume":"54","author":"Riwanto","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0041","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2004.12.030","article-title":"Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice","volume":"181","author":"Rozenberg","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0042","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)01429-6","article-title":"Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice","volume":"34","author":"Rozenberg","year":"2003","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.ajpc.2025.101073_bib0043","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0044","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1073\/pnas.89.21.10316","article-title":"High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors","volume":"89","author":"Bowry","year":"1992","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.ajpc.2025.101073_bib0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M800607-JLR200","article-title":"HDL is the major lipoprotein carrier of plasma F2-isoprostanes","volume":"50","author":"Proudfoot","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0046","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/bj3140739","article-title":"Rapid reduction and removal of HDL-but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ","volume":"314","author":"CHRISTISON","year":"1996","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.ajpc.2025.101073_bib0047","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/iub.588","article-title":"Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation","volume":"64","author":"Hine","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ajpc.2025.101073_bib0049","first-page":"772","article-title":"Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation","volume":"63","author":"Hine","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ajpc.2025.101073_bib0050","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/eurheartj\/ehz114","article-title":"Elevated high-density lipoprotein in adolescents with type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation","volume":"40","author":"Chiesa","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0051","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","article-title":"Biological consequences of dysfunctional HDL","volume":"26","author":"Pirillo","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0052","article-title":"Regulatory T cells and atherosclerosis","volume":"2012","author":"Pastrana","year":"2012","journal-title":"J Clin Exp Cardiolog"},{"key":"10.1016\/j.ajpc.2025.101073_bib0053","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/IAI.68.5.2410-2417.2000","article-title":"Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes","volume":"68","author":"Vesy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpc.2025.101073_bib0054","doi-asserted-by":"crossref","first-page":"12172","DOI":"10.1074\/jbc.271.21.12172","article-title":"Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein (\u2217)","volume":"271","author":"Hailman","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0055","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/cvr\/cvz068","article-title":"Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity","volume":"115","author":"Bonacina","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0056","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","article-title":"The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis","volume":"10","author":"Porte","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0057","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","article-title":"Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis","volume":"120","author":"Norata","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0058","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbadis.2016.03.007","article-title":"Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation","volume":"1862","author":"Bonacina","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.ajpc.2025.101073_bib0059","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/ATVBAHA.108.163204","article-title":"PTX3, and Vascular protection","volume":"28","author":"Mallat","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1078-5884(03)00385-X","article-title":"Prostacyclin: A vascular mediator","volume":"26","author":"Vane","year":"2003","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1016\/j.ajpc.2025.101073_bib0061","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1373\/clinchem.2016.257725","article-title":"The changing face of HDL and the best way to measure it","volume":"63","author":"Karathanasis","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0062","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1006\/bbrc.2000.2877","article-title":"High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis","volume":"272","author":"Sugano","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpc.2025.101073_bib0063","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/ijms21030732","article-title":"Advances in HDL: much more than lipid transporters","volume":"21","author":"Ben-Aicha","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0064","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1194\/jlr.RA119000509","article-title":"HDL inhibits endoplasmic reticulum stress-induced apoptosis of pancreatic \u03b2-cells in vitro by activation of Smoothened [S]","volume":"61","author":"Yalcinkaya","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/cells10051061","article-title":"HDL In immune-inflammatory responses: implications beyond cardiovascular diseases","volume":"10","author":"Bonacina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpc.2025.101073_bib0066","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.10.018","article-title":"HDL functionality in type 1 diabetes","volume":"267","author":"Ganjali","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00258","article-title":"HDL and glucose metabolism: current evidence and therapeutic potential","author":"Siebel","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0068","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11883-006-0038-4","article-title":"High-density lipoprotein: is it always atheroprotective?","volume":"8","author":"Ansell","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2025.101073_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-021-02443-9","article-title":"HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clim.2010.06.014","article-title":"Dysfunctional, pro-inflammatory HDL directly upregulates monocyte pdgfr\u03b2, chemotaxis and tnf\u03b1 production","volume":"137","author":"Skaggs","year":"2010","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0071","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1074\/jbc.M111.337345","article-title":"Myeloperoxidase targets apolipoprotein AI, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions","volume":"287","author":"Shao","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0072","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2012.10.022","article-title":"Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes","volume":"99","author":"Murakami","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajpc.2025.101073_bib0073","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-023-01805-8","article-title":"Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants","volume":"22","author":"Kim","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0074","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-006-0033-9","article-title":"Apolipoprotein AI and risk for cardiovascular diseases","volume":"8","author":"Khuseyinova","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2025.101073_bib0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nature Reviews Cardiology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0076","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1194\/jlr.M004085","article-title":"Oxidation of apolipoprotein AI by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export 1","volume":"51","author":"Shao","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0077","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.ajpc.2025.101073_bib0078","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Undurti","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0079","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211010371","article-title":"Abnormal levels of apolipoprotein AI in chronic thromboembolic pulmonary hypertension","volume":"11","author":"Khirfan","year":"2021","journal-title":"Pulm Circ"},{"key":"10.1016\/j.ajpc.2025.101073_bib0080","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1074\/jbc.M109.047472","article-title":"The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor","volume":"284","author":"Tang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0081","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0082","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1074\/jbc.M109.017202","article-title":"Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein","volume":"284","author":"Watanabe","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0083","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1074\/jbc.M702163200","article-title":"Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic\/hyperlipidemic mice: a novel biomarker of atherosclerosis","volume":"282","author":"Watanabe","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0084","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2018.12.002","article-title":"Adverse interaction between HDL and the mass of myocardial infarction","volume":"281","author":"Soares","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12872-023-03383-9","article-title":"Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention)","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ajpc.2025.101073_bib0086","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0087","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1253\/circj.71.186","article-title":"Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes","volume":"71","author":"Kosuge","year":"2007","journal-title":"Circulation Journal"},{"key":"10.1016\/j.ajpc.2025.101073_bib0088","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1179\/135100009X12525712409490","article-title":"A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis","volume":"14","author":"Hua","year":"2009","journal-title":"Redox Report"},{"key":"10.1016\/j.ajpc.2025.101073_bib0089","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","article-title":"Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition","volume":"261","author":"Coetzee","year":"1986","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0090","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.3760\/cma.j.issn.0366-6999.20130400","article-title":"The relationship between serum amyloid A and apolipoprotein AI in high-density lipoprotein isolated from patients with coronary heart disease","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ajpc.2025.101073_bib0091","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-2275(20)39863-1","article-title":"Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux","volume":"36","author":"Banka","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0092","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.20.3.763","article-title":"Role of serum amyloid A during metabolism of acute-phase HDL by macrophages","volume":"20","author":"Artl","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0093","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0094","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.ajpc.2025.101073_bib0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10157-013-0865-x","article-title":"Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease","volume":"18","author":"Rye","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0096","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein AI","volume":"30","author":"Nob\u00e9court","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0097","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","article-title":"Modifying apolipoprotein AI by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway","volume":"285","author":"Shao","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0098","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/joim.12290","article-title":"Acquired lecithin: cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease","volume":"277","author":"Calabresi","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0099","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/ijms20051202","article-title":"Plasma levels of pre\u03b21-HDL are significantly elevated in non-dialyzed patients with advanced stages of chronic kidney disease","volume":"20","author":"Kuchta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0100","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2014030309","article-title":"Dialysis modalities and HDL composition and function","volume":"26","author":"Holzer","year":"2015","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.ajpc.2025.101073_bib0101","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/ki.1997.263","article-title":"Down-regulation of hepatic lipase expression in experimental nephrotic syndrome","volume":"51","author":"Liang","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpc.2025.101073_bib0102","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.ajpc.2025.101073_bib0103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","article-title":"High-density lipoprotein function and dysfunction in health and disease","volume":"33","author":"Chiesa","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0104","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein AI is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0105","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","article-title":"Protein carbamylation renders high-density lipoprotein dysfunctional","volume":"14","author":"Holzer","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ajpc.2025.101073_bib0106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2017.05.001","article-title":"Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD","volume":"112","author":"Ganda","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.metabol.2014.10.020","article-title":"Dysfunctional high-density lipoproteins in children with chronic kidney disease","volume":"64","author":"Kaseda","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.06.005","article-title":"Effect of chronic kidney disease on macrophage cholesterol efflux","volume":"136","author":"Meier","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0109","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0110","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD (P) H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"T\u00f6lle","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","article-title":"Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease","volume":"153","author":"Moradi","year":"2009","journal-title":"Translational Research"},{"key":"10.1016\/j.ajpc.2025.101073_bib0112","article-title":"Diminished antioxidant activity of high-density lipoprotein\u2013associated proteins in chronic kidney disease","volume":"2","author":"Kennedy","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101073_bib0113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arcmed.2015.05.009","article-title":"Residual cardiovascular risk in chronic kidney disease: role of high-density lipoprotein","volume":"46","author":"Kon","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0114","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ajpc.2025.101073_bib0115","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.ajpc.2025.101073_bib0116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020601","article-title":"The role and function of HDL in patients with chronic kidney disease and the risk of cardiovascular disease","volume":"21","author":"Rysz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0117","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ki.2014.218","article-title":"The urea decomposition product cyanate promotes endothelial dysfunction","volume":"86","author":"El-Gamal","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpc.2025.101073_bib0118","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"Schofield","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0119","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tem.2020.01.015","article-title":"Dyslipidemia in type 1 diabetes: AMaskedDanger","volume":"31","author":"Verg\u00e8s","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2025.101073_bib0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.5551\/jat.24315","article-title":"Relationship between serum cholesterol efflux capacity and glucose intolerance in Japanese-Americans","volume":"21","author":"Kubota","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ajpc.2025.101073_bib0121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.diabres.2012.12.012","article-title":"Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria","volume":"99","author":"Sampaio","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajpc.2025.101073_bib0122","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/2047487319894114","article-title":"Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease","volume":"27","author":"Feng","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0123","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/db10-0371","article-title":"Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes","volume":"59","author":"Jaleel","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpc.2025.101073_bib0124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ki.2009.205","article-title":"Potential restoration of HDL function with apolipoprotein AI mimetic peptide in end-stage renal disease","volume":"76","author":"Kaysen","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpc.2025.101073_bib0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc19-0772","article-title":"High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes","volume":"43","author":"Vaisar","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2025.101073_bib0126","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0127","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diabetes.53.3.513","article-title":"Transcriptional control of apolipoprotein A-I gene expression in diabetes","volume":"53","author":"Mooradian","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpc.2025.101073_bib0128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00041433-200006000-00008","article-title":"Hepatic lipase and HDL metabolism","volume":"11","author":"Thuren","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0129","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajpc.2025.101073_bib0131","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpc.2025.101073_bib0132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/JCSR.JCSR_108_19","article-title":"High-density lipoprotein: quality versus quantity in type 2 diabetes mellitus","volume":"8","author":"Bitla","year":"2019","journal-title":"Journal of Clinical and Scientific Research"},{"key":"10.1016\/j.ajpc.2025.101073_bib0133","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0000000000000217","article-title":"Kidneys: key modulators of high-density lipoprotein levels and function","volume":"25","author":"Yang","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ajpc.2025.101073_bib0134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-020-00901-4","article-title":"High-density lipoproteins and serum amyloid A (SAA)","volume":"23","author":"Webb","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2025.101073_bib0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/cells10051041","article-title":"The endothelium is both a target and a barrier of HDL\u2019s protective functions","volume":"10","author":"Robert","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpc.2025.101073_bib0136","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/jcm10112233","article-title":"Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: molecular mechanisms and therapeutic implications","volume":"10","author":"Bonilha","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0137","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1042\/CS20190873","article-title":"Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL","volume":"133","author":"Hui","year":"2019","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/eurheartj\/ehp399","article-title":"Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors","volume":"31","author":"Chapman","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0139","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1073\/pnas.0802025105","article-title":"Methionine oxidation impairs reverse cholesterol transport by apolipoprotein AI","volume":"105","author":"Shao","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.ajpc.2025.101073_bib0140","first-page":"198","article-title":"Pathways for oxidation of high-density lipoprotein in human cardiovascular disease","volume":"8","author":"Shao","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0141","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/cells10040850","article-title":"High density lipoproteins and diabetes","volume":"10","author":"Cochran","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpc.2025.101073_bib0142","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/ijms19061680","article-title":"The role of high-density lipoproteins in diabetes and its vascular complications","volume":"19","author":"Wong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0143","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/clp.13.83","article-title":"Dysfunctional HDL: the journey from savior to slayer","volume":"9","author":"Serban","year":"2014","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0144","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erc.11.182","article-title":"HDL dysfunction in diabetes: causes and possible treatments","volume":"10","author":"Farbstein","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in vivo","volume":"222","author":"de la","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0146","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022142","article-title":"Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function","volume":"6","author":"Patel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2025.101073_bib0148","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.M109977200","article-title":"Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2025.101073_bib0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2016.04.012","article-title":"The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis","volume":"457","author":"Yamamoto","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.ajpc.2025.101073_bib0151","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.7754\/Clin.Lab.2016.150412","article-title":"Oxidized low-density lipoprotein (ox-LDL) to LDL ratio (ox-LDL\/LDL) and ox-LDL to high-density lipoprotein ratio (ox-LDL\/HDL)","volume":"62","author":"Motamed","year":"2016","journal-title":"Clin Lab"},{"key":"10.1016\/j.ajpc.2025.101073_bib0152","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00380-014-0543-2","article-title":"Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation","volume":"30","author":"Pers\u00e9gol","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ajpc.2025.101073_bib0153","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0154","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051061","article-title":"HDL in immune-inflammatory responses: implications beyond cardiovascular diseases","volume":"10","author":"Bonacina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpc.2025.101073_bib0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL cholesterol: reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0156","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0157","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trsl.2016.02.008","article-title":"Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy","volume":"173","author":"Annema","year":"2016","journal-title":"Translational Research"},{"key":"10.1016\/j.ajpc.2025.101073_bib0158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nature reviews cardiology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0159","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7570\/jomes.2018.27.3.195","article-title":"Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance service health checkup data 2006\u20132015 (J Obes Metab Syndr 2018; 27: 46\u201352)","volume":"27","author":"Yoon","year":"2018","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.ajpc.2025.101073_bib0160","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","article-title":"Phospholipase A2 enzymes and the risk of atherosclerosis","volume":"33","author":"Rosenson","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101073_bib0161","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41598-017-07821-5","article-title":"Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients","volume":"7","author":"Carnuta","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpc.2025.101073_bib0162","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/cvr\/cvu139","article-title":"High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease","volume":"103","author":"Kratzer","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0163","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0164","article-title":"Coronary artery calcium for risk stratification among persons with very high HDL cholesterol","volume":"3","author":"Razavi","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.ajpc.2025.101073_bib0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/art.41059","article-title":"High-density lipoprotein in lupus: disease biomarkers and potential therapeutic strategy","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis & rheumatology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0166","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2036.2008.03886.x","article-title":"Plasma lipids and inflammation in active inflammatory bowel diseases","volume":"29","author":"Romanato","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajpc.2025.101073_bib0167","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biomedicines8120558","article-title":"High-density lipoprotein (HDL) in allergy and skin diseases: focus on immunomodulating functions","volume":"8","author":"Trakaki","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpc.2025.101073_bib0168","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2021.12.009","article-title":"High-density lipoproteins and immune response: A review","volume":"195","author":"Grao-Cruces","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0169","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0170","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity [S]","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0171","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0022-2275(20)31621-7","article-title":"Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase 1","volume":"42","author":"Khovidhunkit","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0172","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13105-019-00694-4","article-title":"Alterations of HDL particle phospholipid composition and role of inflammation in rheumatoid arthritis","volume":"75","author":"Giraud","year":"2019","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0173","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.4049\/jimmunol.172.12.7821","article-title":"Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus","volume":"172","author":"Krishnan","year":"2004","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.ajpc.2025.101073_bib0174","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft\u2013associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus","volume":"113","author":"Jury","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.numecd.2014.01.006","article-title":"Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. Nutrition","volume":"24","author":"Ammirati","year":"2014","journal-title":"Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.ajpc.2025.101073_bib0176","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Charles-Schoeman","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0177","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/jcm9072157","article-title":"Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study","volume":"9","author":"Greco","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0178","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/pr5011586","article-title":"Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis","volume":"14","author":"Marsillach","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0179","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2016-209683","article-title":"Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity","volume":"76","author":"Smith","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0180","article-title":"Neutrophil extracellular traps (NETs) and atherosclerosis: does hypolipidemic treatment have an effect?","volume":"11","author":"Adamidis","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0181","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.3390\/ijms21207472","article-title":"Early pro-inflammatory remodeling of HDL proteome in a model of diet-induced obesity: 2H2O-metabolic labeling-based kinetic approach","volume":"21","author":"Sadana","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0182","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12165405","article-title":"HDL cholesterol efflux and the complement system are linked in systemic Lupus erythematosus","volume":"12","author":"Garc\u00eda-Gonz\u00e1lez","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0183","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1016\/S0021-9258(18)99123-4","article-title":"Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein AI in human plasma","volume":"266","author":"Jenne","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s102380200004","article-title":"Relationship between serum complement and different lipid disorders","volume":"2","author":"Pasqui","year":"2002","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12070-015-0829-4","article-title":"Alteration of lipid profile in patients with head and neck malignancy","volume":"68","author":"Poorey","year":"2016","journal-title":"Indian Journal of Otolaryngology and Head & Neck Surgery"},{"key":"10.1016\/j.ajpc.2025.101073_bib0186","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-16555-4_6","article-title":"Synthetic high-density lipoprotein-like nanoparticles as cancer therapy","volume":"166","author":"McMahon","year":"2015","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0187","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.2910430523","article-title":"Effects of low-and high-density lipoproteins on the proliferation of human breast cancer cells In vitro: differences between hormone-dependent and hormone-independent cell lines","volume":"43","author":"Rotheneder","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpc.2025.101073_bib0188","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.coph.2012.07.009","article-title":"Cholesterol and breast cancer development","volume":"12","author":"Danilo","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0189","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1593\/neo.101372","article-title":"Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles","volume":"13","author":"Shahzad","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.ajpc.2025.101073_bib0191","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr3483","article-title":"Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development","volume":"15","author":"Danilo","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0192","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s13277-015-4141-4","article-title":"High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer","volume":"37","author":"Yuan","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0193","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.18632\/oncotarget.397","article-title":"Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins","volume":"2","author":"Vainio","year":"2011","journal-title":"Oncotarget"},{"issue":"Pt A","key":"10.1016\/j.ajpc.2025.101073_bib0194","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biochi.2014.09.023","article-title":"Secreted phospholipases A2 in cancer: diverse mechanisms of action","volume":"107","author":"Brglez","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ajpc.2025.101073_bib0195","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.jacc.2009.12.069","article-title":"Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy","volume":"55","author":"Jafri","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0196","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2013.00119","article-title":"The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics","volume":"4","author":"Cruz","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0197","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clinbiochem.2018.11.010","article-title":"Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer","volume":"63","author":"Mihajlovic","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0198","first-page":"243","article-title":"The complex interplay between cholesterol and prostate malignancy","volume":"38","author":"Solomon","year":"2011","journal-title":"Urologic Clinics"},{"key":"10.1016\/j.ajpc.2025.101073_bib0199","doi-asserted-by":"crossref","first-page":"42978","DOI":"10.18632\/oncotarget.7160","article-title":"High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpc.2025.101073_bib0200","first-page":"2236","article-title":"High density lipoproteins inhibit oxidative stress-induced","volume":"8","author":"Ruscica","year":"2018","journal-title":"Prostate Cancer Cell Proliferation. Sci Rep"},{"key":"10.1016\/j.ajpc.2025.101073_bib0201","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/cam4.1987","article-title":"Correlation between immune signature and high-density lipoprotein cholesterol level in stage II\/III colorectal cancer","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0202","doi-asserted-by":"crossref","first-page":"839","DOI":"10.17235\/reed.2019.6201\/2019","article-title":"Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer","volume":"111","author":"Yuan","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.ajpc.2025.101073_bib0203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2018.10.004","article-title":"High-density lipoprotein components and functionality in cancer: State-of-the-art","volume":"30","author":"Ganjali","year":"2019","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0204","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215246","article-title":"Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism","volume":"14","author":"Zab\u0142ocka-S\u0142owi\u0144ska","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2025.101073_bib0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1479-5876-10-65","article-title":"Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis","volume":"10","author":"Pan","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0206","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.plipres.2018.06.001","article-title":"High density lipoprotein cholesterol and cancer: marker or causative?","volume":"71","author":"Pirro","year":"2018","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0207","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4048\/jbc.2013.16.2.159","article-title":"Cholesterol acyltransferase and Na+-K+-ATPase activity in patients with breast cancer","volume":"16","author":"\u00d6zmen","year":"2013","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.ajpc.2025.101073_bib0208","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11745-997-0020-5","article-title":"Impaired cholesterol esterification in the plasma in patients with breast cancer","volume":"32","author":"Subbaiah","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0209","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.prnil.2017.04.002","article-title":"Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-na\u00efve patients","volume":"6","author":"Asare","year":"2018","journal-title":"Prostate Int"},{"key":"10.1016\/j.ajpc.2025.101073_bib0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12967-019-1850-2","article-title":"Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study","volume":"17","author":"Fredslund","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0211","first-page":"679","article-title":"Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer","volume":"30","author":"Arioz","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0212","first-page":"e1","article-title":"The predictive role of paraoxonase 1 (PON1) activity on survival in patients with metastatic and nonmetastatic gastric cancer","volume":"165","author":"Atay","year":"2014","journal-title":"Clin Ter"},{"key":"10.1016\/j.ajpc.2025.101073_bib0213","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2407-7-48","article-title":"Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population","volume":"7","author":"Elkiran","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpc.2025.101073_bib0214","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5114\/aoms.2016.59674","article-title":"Phenotype distribution of the paraoxonase gene in patients with cardiac disease","volume":"13","author":"Ellidag","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fendo.2020.00176","article-title":"Subclinical hyperthyroidism: status of the cholesterol transfers to HDL and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer","volume":"11","author":"Sigal","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajpc.2025.101073_bib0216","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.numecd.2008.06.002","article-title":"Serum lipoproteins and cancer. Nutrition","volume":"19","author":"Muntoni","year":"2009","journal-title":"Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.ajpc.2025.101073_bib0217","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cbf.1284","article-title":"Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas","volume":"24","author":"Kafadar","year":"2006","journal-title":"Cell Biochemistry and Function: Cellular biochemistry and its modulation by active agents or disease"},{"key":"10.1016\/j.ajpc.2025.101073_bib0218","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0219","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free radical biology and medicine"},{"key":"10.1016\/j.ajpc.2025.101073_bib0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3164\/jcbn.R09-66","article-title":"Bioimaging probes for reactive oxygen species and reactive nitrogen species","volume":"45","author":"Nagano","year":"2009","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.ajpc.2025.101073_bib0221","article-title":"Paraoxonase 1, HDL subclasses and post surgery acute inflammation: A pilot study","volume":"8","author":"Bains","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ajpc.2025.101073_bib0222","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0223","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.113.301300","article-title":"Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium","volume":"33","author":"Tatematsu","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0224","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21873\/cgp.20118","article-title":"Serum proteomic signatures of male breast cancer","volume":"16","author":"Zografos","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.ajpc.2025.101073_bib0225","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpc.2025.101073_bib0226","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2025.101073_bib0227","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/jc.2005-0019","article-title":"The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity","volume":"90","author":"Martin","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0228","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs1030137","article-title":"Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population","volume":"103","author":"Yamamoto","year":"2002","journal-title":"Clin Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0229","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238985","article-title":"Obesity-related changes in high-density lipoprotein metabolism and function","volume":"21","author":"Stadler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpc.2025.101073_bib0230","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCULATIONAHA.111.058453","article-title":"Adipose modulation of high-density lipoprotein cholesterol: implications for obesity, high-density lipoprotein metabolism, and cardiovascular disease","volume":"124","author":"McGillicuddy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0231","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154393","article-title":"Adiponectin's mechanisms in high-density lipoprotein biogenesis and cholesterol efflux","volume":"113","author":"Hafiane","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0232","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.numecd.2010.01.014","article-title":"Plasma adiponectin is associated with less atherogenic lipoprotein phenotype","volume":"21","author":"Shin","year":"2011","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.ajpc.2025.101073_bib0233","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2337\/dc09-0084","article-title":"Adiponectin and lipoprotein particle size","volume":"32","author":"Weiss","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2025.101073_bib0234","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpc.2025.101073_bib0235","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","article-title":"Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024","volume":"18","author":"Bays","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0236","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0026-0495(81)90028-7","article-title":"Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: response to glucose and to semistarvation","volume":"30","author":"Taskinen","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case\u2013control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-10-176","article-title":"New insights into the mechanism of low high-density lipoprotein cholesterol in obesity","volume":"10","author":"Wang","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0239","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1056-8727(01)00191-X","article-title":"The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states","volume":"16","author":"Rashid","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ajpc.2025.101073_bib0240","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1194\/jlr.M078667","article-title":"Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease [S]","volume":"58","author":"Davidson","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0241","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbalip.2006.11.003","article-title":"Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus","volume":"1771","author":"Dullaart","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0242","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/S0022-2275(20)41091-0","article-title":"Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content","volume":"36","author":"Radeau","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0243","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11010-022-04563-5","article-title":"Effects of superoxide anion attack on the lipoprotein HDL","volume":"478","author":"Napolitano","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajpc.2025.101073_bib0244","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.928566","article-title":"Glycosylation of HDL-associated proteins and its implications in cardiovascular disease diagnosis, metabolism and function","volume":"9","author":"Romo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0245","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","article-title":"High-density lipoprotein subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts","volume":"137","author":"Jensen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0246","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCRESAHA.112.273656","article-title":"Leptin signaling in adipose tissue: role in lipid accumulation and weight gain","volume":"111","author":"Singh","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0247","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1172\/JCI119422","article-title":"Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression","volume":"99","author":"L\u00f6nnqvist","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0248","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M302645200","article-title":"Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7\u03b1-hydroxylase (Cyp7a1) in leptin-deficient (ob\/ob) mice","volume":"278","author":"Lund\u00e5sen","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0249","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI16306","article-title":"Endothelial lipase is a major determinant of HDL level","volume":"111","author":"Ishida","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0250","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0030022","article-title":"Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis","volume":"3","author":"Badellino","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpc.2025.101073_bib0251","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/oby.2012.126","article-title":"Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance","volume":"20","author":"Blachnio-Zabielska","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.ajpc.2025.101073_bib0252","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.ajpc.2025.101073_bib0253","doi-asserted-by":"crossref","first-page":"31780","DOI":"10.1074\/jbc.M104353200","article-title":"Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells","volume":"276","author":"Kimura","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0254","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072449","article-title":"Plasma sphingosine-1-phosphate is elevated in obesity","volume":"8","author":"Kowalski","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2025.101073_bib0255","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2107178","article-title":"HDL subclass distribution shifts with increasing Central adiposity","author":"Woudberg","year":"2019","journal-title":"J Obes"},{"key":"10.1016\/j.ajpc.2025.101073_bib0256","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.117.309275","article-title":"A shift in ApoM\/S1P between HDL-particles in women with type 1 diabetes mellitus is associated with impaired anti-inflammatory effects of the ApoM\/S1P complex","volume":"37","author":"Frej","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0257","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/2230-8210.111618","article-title":"Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia","volume":"17","author":"Kota","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2025.101073_bib0258","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","article-title":"Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy","volume":"121","author":"Sorrentino","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0259","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00125-006-0244-1","article-title":"Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation","volume":"49","author":"Persegol","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2025.101073_bib0260","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-2275(20)33293-4","article-title":"Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects","volume":"39","author":"Sasahara","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0261","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1210\/jc.2017-00933","article-title":"Adiponectin predicts high-density lipoprotein cholesterol efflux capacity in adults irrespective of body mass index and fat distribution","volume":"102","author":"Marsche","year":"2017","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0262","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2018.04.029","article-title":"HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men","volume":"274","author":"Talbot","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0263","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/ATVBAHA.117.309287","article-title":"Impairment of the ability of HDL from patients with metabolic syndrome but without diabetes mellitus to activate eNOS","volume":"37","author":"Denimal","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0264","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/jc.2004-0486","article-title":"Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females","volume":"90","author":"Ferretti","year":"2005","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.plefa.2004.10.021","article-title":"Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome","volume":"72","author":"Rizos","year":"2005","journal-title":"Prostaglandins, leukotrienes and essential fatty acids"},{"key":"10.1016\/j.ajpc.2025.101073_bib0266","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpc.2025.101073_bib0267","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.ATV.18.6.999","article-title":"Estradiol stimulates apolipoprotein A-I\u2013 but not A-II\u2013Containing particle synthesis and secretion by stimulating mRNA transcription rate in hep G2 cells","volume":"18","author":"Jin","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0268","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117270","article-title":"Sex differences in lipids: A life course approach","volume":"384","author":"Holven","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101073_bib0269","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/jamacardio.2021.3490","article-title":"Premature menopause and 10-year risk prediction of atherosclerotic cardiovascular disease","volume":"6","author":"Freaney","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0270","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/ATVBAHA.118.311017","article-title":"HDL (High-Density Lipoprotein) metrics and atherosclerotic risk in women","volume":"38","author":"El Khoudary","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0271","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacl.2016.04.008","article-title":"Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression","volume":"10","author":"El Khoudary","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0272","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/ATVBAHA.120.315355","article-title":"HDL (High-Density Lipoprotein) subclasses, lipid content, and function trajectories across the menopause transition","volume":"41","author":"El Khoudary","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0273","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100098","article-title":"Associations of HDL metrics with coronary artery calcium score and density among women traversing menopause","volume":"62","author":"El Khoudary","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0274","unstructured":"GeneCards: The Human Gene Database., 2025."},{"key":"10.1016\/j.ajpc.2025.101073_bib0275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJM198603133141102","article-title":"Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia","volume":"314","author":"Ordovas","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ajpc.2025.101073_bib0276","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041433-200304000-00007","article-title":"Apolipoprotein A-I(Milano): current perspectives","volume":"14","author":"Chiesa","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0277","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/bi011716p","article-title":"Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I","volume":"41","author":"Bielicki","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpc.2025.101073_bib0278","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial lecithin:cholesterol acyltransferase deficiency is differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101073_bib0279","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-0495(97)90180-3","article-title":"Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins","volume":"46","author":"Elkhalil","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0280","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpc.2025.101073_bib0281","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamacardio.2017.4177","article-title":"Association of CETP gene variants with risk for vascular and nonvascular diseases among Chinese adults","volume":"3","author":"Millwood","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101073_bib0282","first-page":"11","article-title":"Hyperalphalipoproteinemia and beyond: the role of HDL in cardiovascular diseases","author":"Giammanco","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ajpc.2025.101073_bib0283","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.120.318793","article-title":"Inherited variants in SCARB1Cause severe early-onset coronary artery disease","volume":"129","author":"Koenig","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.101073_bib0284","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1210\/jc.2008-1342","article-title":"Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease","volume":"94","author":"Johannsen","year":"2009","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.ajpc.2025.101073_bib0285","first-page":"54","article-title":"The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans","volume":"6","author":"Singaraja","year":"2013","journal-title":"Circulation: Cardiovascular Genetics"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T21:01:14Z","timestamp":1760648474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":285,"alternative-id":["S2666667725001485"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101073","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoproteins. Part 2. Impact of disease states on functionality","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101073"}}